COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joseph Ciaffoni on Q2 2020 Results - Earnings Call Transcript
Collegium Pharmaceutical, Inc. (COLL)
Q2 2020 Earnings Conference Call
August 05, 2020, 16:30 ET
Company Participants
Alex Dasalla - Head, IR
Joseph Ciaffoni - President, CEO & Director
Paul Brannelly - EVP & CFO
Scott Dreyer - EVP & Chief Commercial Officer
Conference Call Participants
David Steinberg - Jefferies
Gregory Gilbert - Truist Securities
Serge Belanger - Needham & Company
Brandon Folkes - Cantor Fitzgerald & Co.
Dana Flanders - Guggenheim Securities
David Amsellem - Piper Sandler & Co.
Presentation
Operator
Greetings, and welcome to the Collegium Pharmaceuticals Second Quarter 2020 Earnings Conference Call. [Operator